標(biāo)題: Titlebook: Breast Cancer; Nuclear Medicine in Emilio Bombardieri,Luca Gianni,Gianni Bonadonna (C Book 2008 Springer-Verlag Berlin Heidelberg 2008 Bre [打印本頁(yè)] 作者: 呻吟 時(shí)間: 2025-3-21 17:02
書目名稱Breast Cancer影響因子(影響力)
書目名稱Breast Cancer影響因子(影響力)學(xué)科排名
書目名稱Breast Cancer網(wǎng)絡(luò)公開(kāi)度
書目名稱Breast Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Breast Cancer被引頻次
書目名稱Breast Cancer被引頻次學(xué)科排名
書目名稱Breast Cancer年度引用
書目名稱Breast Cancer年度引用學(xué)科排名
書目名稱Breast Cancer讀者反饋
書目名稱Breast Cancer讀者反饋學(xué)科排名
作者: Projection 時(shí)間: 2025-3-21 21:07 作者: obligation 時(shí)間: 2025-3-22 02:26 作者: 精美食品 時(shí)間: 2025-3-22 07:19
Internationale Wirtschaftsbeziehungen,mmographic screening can decrease the death rate due to BC (Daniel and Kopans 2004; Tabar et al. 2001). Nevertheless, this technique has some limitations that reduce its accuracy (Berlin 2001): not all BCs are evident on mammograms, especially in dense or dysplastic breasts (Birdwell et al. 2001), e作者: 放逐 時(shí)間: 2025-3-22 12:06
Aktuelle Fragen der Wechselkurstheorie,h into disease-specific biochemical processes have advanced the development of molecular biomarkers as targets for molecular imaging..A biomarker can be defined as a measurable variable of a molecular, biological or functional process that can also be used as a measure of pharmacologic response to t作者: 手術(shù)刀 時(shí)間: 2025-3-22 13:31 作者: emulsify 時(shí)間: 2025-3-22 17:08 作者: 羅盤 時(shí)間: 2025-3-22 22:00 作者: Bumble 時(shí)間: 2025-3-23 04:07
Bernhard Felderer,Stefan Homburg imaging methods..Limitations of FDG PET in the follow-up of breast cancer patients include the relatively low detection rate of bone metastases, especially in case of sclerotic subtype, and the relatively high rate of false-positive results. The rather low specificity of FDG PET can be improved/inc作者: blister 時(shí)間: 2025-3-23 07:45 作者: 輕觸 時(shí)間: 2025-3-23 13:45
Bernhard Felderer,Stefan Homburgappropriate postoperative treatments. Nodal status, tumor size, tumor grade, age and HER2 expression are universally accepted as important factors to define risk categories. Newer factors such as uPA/PAI-1, cyclin-E and other proliferative indices and the gene expression profile are promising and wi作者: 有害 時(shí)間: 2025-3-23 14:38 作者: FELON 時(shí)間: 2025-3-23 21:30 作者: 嬉耍 時(shí)間: 2025-3-24 01:38
Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT wisiveness and morbidity. However, ALND may not be necessary in many cases, in particular in early stage carcinomas with tumor size <10 mm and even more so when axillary clinical examination is negative, since in this case the percentage of lymph node metastases is very low. Moreover, even when axilla作者: OFF 時(shí)間: 2025-3-24 03:23 作者: 外貌 時(shí)間: 2025-3-24 06:55
PET Imaging of Breast Cancer Molecular Biomarkers,h into disease-specific biochemical processes have advanced the development of molecular biomarkers as targets for molecular imaging..A biomarker can be defined as a measurable variable of a molecular, biological or functional process that can also be used as a measure of pharmacologic response to t作者: eustachian-tube 時(shí)間: 2025-3-24 13:08 作者: 引起痛苦 時(shí)間: 2025-3-24 18:03
FDG-PET in Monitoring Therapy of Breast Cancer,onitoring chemotherapy in breast cancer..Whole body imaging with fluorine-18 deoxyglucose PET (FDG-PET) has gained widespread acceptance for the staging and restaging of breast cancer (Biersack et at. 2001; Kostakoglu and Goldsmith 2003; Grahek et al. 2004). Another significant indication for FDG-PE作者: 山羊 時(shí)間: 2025-3-24 22:27
FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer,n screening and early diagnosis; it has an established role in the diagnosis of recurrences; it has an established role in therapy monitoring, alone or in association with other diagnostic tools; it is still under study as a predictor of response to therapy. Several international guidelines help phy作者: Conserve 時(shí)間: 2025-3-25 02:39
Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer, imaging methods..Limitations of FDG PET in the follow-up of breast cancer patients include the relatively low detection rate of bone metastases, especially in case of sclerotic subtype, and the relatively high rate of false-positive results. The rather low specificity of FDG PET can be improved/inc作者: 微枝末節(jié) 時(shí)間: 2025-3-25 06:32 作者: 細(xì)胞 時(shí)間: 2025-3-25 11:28
Progress in the Treatment of Early and Advanced Breast Cancer,appropriate postoperative treatments. Nodal status, tumor size, tumor grade, age and HER2 expression are universally accepted as important factors to define risk categories. Newer factors such as uPA/PAI-1, cyclin-E and other proliferative indices and the gene expression profile are promising and wi作者: 華而不實(shí) 時(shí)間: 2025-3-25 12:01
Overview: Brings up-to-date nuclear medical knowledge in breast cancer.Information on the advances in the field of diagnosis.Data on the development of some new modalities.General overview of the available tool978-3-642-07186-7978-3-540-36781-9作者: 空洞 時(shí)間: 2025-3-25 16:35
Die Berücksichtigung von Verm?genseffekteno study breast tumours. Besides the different options among the imaging modalities, other aspects are overviewed including the biology and histology of breast cancer as well as the available laboratory tests and treatments. One chapter is dedicated to the histological classification of breast cancer作者: 小木槌 時(shí)間: 2025-3-25 20:18 作者: EXCEL 時(shí)間: 2025-3-26 01:57
,Einige elementare überlegungen, treatment modalities that are effective in the presence of favourable clinical or patho-biologic features, there is still a great deal of controversy in its clinical management. In the last decades, tumour biomarkers that are indicative of or related to cell traits characterising malignancy, such a作者: crescendo 時(shí)間: 2025-3-26 07:33
Volkswirtschaftliche Gesamtrechnung,urrently used in clinical practice. Serum marker levels reflect tumour burden, and for this reason they are not sensitive enough to be used for screening and early diagnosis of primary breast cancer. By contrast, the role of tumour markers is established in the diagnosis of recurrent disease and in 作者: 無(wú)動(dòng)于衷 時(shí)間: 2025-3-26 08:28 作者: Nausea 時(shí)間: 2025-3-26 14:00
Internationale Wirtschaftsbeziehungen,he female population. It is the second leading cause of death for women following lung cancer, accounting for 15% of all cancer deaths among women in the USA. In 2005, the American Cancer Society estimated 211,240 new cases and 40,410 female deaths from this disease (Jemal et al. 2005). Trends in in作者: Cursory 時(shí)間: 2025-3-26 20:25 作者: Melanoma 時(shí)間: 2025-3-26 23:09
Makro?konomik - Schnell erfasstges in the management of patients affected by early infiltrating breast carcinoma. Sentinel lymph node biopsy (SLNB) was first applied in melanoma patients by Morton and colleagues (Morton et al. 1992); they intra-operatively injected the patent with vital blue dye close to the primary lesion, and t作者: MUMP 時(shí)間: 2025-3-27 03:30 作者: 散步 時(shí)間: 2025-3-27 09:15 作者: Root494 時(shí)間: 2025-3-27 10:50 作者: palette 時(shí)間: 2025-3-27 15:50 作者: LANCE 時(shí)間: 2025-3-27 18:11 作者: SPURN 時(shí)間: 2025-3-27 22:51
Aktuelle Fragen der Wechselkurstheorie,her significant indication is the evaluation of therapy response. There are only few data on FDGPET in breast cancer after radiation therapy. The same holds true for chemotherapy. Only the therapy response in locally advanced breast cancer after chemotherapy has been investigated thoroughly. Histopa作者: OTTER 時(shí)間: 2025-3-28 02:45 作者: 出來(lái) 時(shí)間: 2025-3-28 08:56
Bernhard Felderer,Stefan Homburgsurgery, chemotherapy and/or external radiotherapy. Despite the low sensitivity and moderate specificity of FDG PET in the initial detection and characterization of breast cancer and the low lesion-based sensitivity for lymph node staging, the results from using FDG PET in re-staging breast cancer p作者: Parallel 時(shí)間: 2025-3-28 14:18 作者: 錫箔紙 時(shí)間: 2025-3-28 17:18
Bernhard Felderer,Stefan Homburged the most useful tool for early diagnosing and monitoring the metastatic spread of breast cancer. In the past years, there has been wide debate on its impact on survival time, morbidity and quality of life. The results of some studies on the asymptomatic patients during follow-up have led to the a作者: epicondylitis 時(shí)間: 2025-3-28 19:32
Bernhard Felderer,Stefan Homburgf increasing incidence, breast cancer mortality is declining in the majority of developed countries. This is the combined result of better education, widespread screening programs and more efficacious adjuvant treatments..The better knowledge of breast cancer biology nowadays allows sparing the cosm作者: 敘述 時(shí)間: 2025-3-29 02:02
https://doi.org/10.1007/978-3-540-36781-9Breast Cancer Diagnosis and Management; Nuclear Medicine Imaging; Nuclear Medicine Therapy; Nuclear Med作者: 微塵 時(shí)間: 2025-3-29 05:21 作者: Manifest 時(shí)間: 2025-3-29 10:42 作者: 顛簸下上 時(shí)間: 2025-3-29 14:03 作者: judiciousness 時(shí)間: 2025-3-29 19:12 作者: 美麗的寫 時(shí)間: 2025-3-29 21:47
https://doi.org/10.1007/978-3-658-41055-1t al. 2004; Corsten et al. 2006; Weissleder 2006). A major purpose in this area is the non-invasive detection of well-known biochemical, molecular and histological markers of tumor aggressiveness, invasiveness and resistance to therapy, which may provide rational criteria for a fine tuning of therapeutic strategies in individual patients.作者: 整頓 時(shí)間: 2025-3-30 00:28
Makro?konomik - Schnell erfasstients by Morton and colleagues (Morton et al. 1992); they intra-operatively injected the patent with vital blue dye close to the primary lesion, and the blue-stained SLN was later found by dissection, following tracer diffusion.作者: Agnosia 時(shí)間: 2025-3-30 07:12
Histological Classification of Breast Cancer,typing of invasive breast cancer, its histological variants and their grading systems are well established. More difficult is the classification of the pre-invasive breast lesions that are now increasingly detected by mammography.作者: Abduct 時(shí)間: 2025-3-30 11:47 作者: 淺灘 時(shí)間: 2025-3-30 12:37 作者: bromide 時(shí)間: 2025-3-30 20:36
Die Berücksichtigung von Verm?genseffektenble results published in the recent literature are analysed. A number of chapters focus on nuclear medicine procedures: scintimammography, sentinel lymph node biopsy after lymphoscintigraphy, bone scintigraphy with .Tc-labelled phosphonates and positron-emission tomography (PET) with .F-fluorodeoxyglucose (FDG).作者: 紳士 時(shí)間: 2025-3-30 21:57 作者: Intentional 時(shí)間: 2025-3-31 01:12
Makro?konomik und neue Makro?konomikmal metabolic changes detected on PET imaging to anatomic structures defined at CT imaging (Townsend 2001)..With this chapter, the impact in breast cancer diagnosis of PET/CT will be evaluated and compared with PET alone, visually correlated with morphologic imaging obtained in a separate session.作者: 防御 時(shí)間: 2025-3-31 05:38 作者: 吊胃口 時(shí)間: 2025-3-31 11:55 作者: Emasculate 時(shí)間: 2025-3-31 16:08 作者: sclera 時(shí)間: 2025-3-31 19:38 作者: bronchodilator 時(shí)間: 2025-3-31 23:20
https://doi.org/10.1007/978-3-662-08450-2o standardise methodology. This is necessary to establish firm cut-off values for discriminating responders from non-responders, which in turn will provide a means for optimal treatment for as many patients as possible.作者: COST 時(shí)間: 2025-4-1 04:49
New Trends of MRI in Breast Cancer Diagnosis,tary inflow of nutritional factors. For this reason, they are able to release some specific proteins that induce new vessel growth (vascular endothelial growth factor, VEGF) (Folkman 1985, Folkman et al. 1987; Folkman 2002; Weidner et al. 1991; Hanahan et al. 1996; Gimbrone et al. 1972).作者: Jargon 時(shí)間: 2025-4-1 06:43 作者: 喪失 時(shí)間: 2025-4-1 11:38
Introduction,o study breast tumours. Besides the different options among the imaging modalities, other aspects are overviewed including the biology and histology of breast cancer as well as the available laboratory tests and treatments. One chapter is dedicated to the histological classification of breast cancer作者: kidney 時(shí)間: 2025-4-1 14:35
Histological Classification of Breast Cancer,n life style. Risk factors include early menarche and late childbirth. Breast cancer is further characterized by a marked genetic susceptibility. The typing of invasive breast cancer, its histological variants and their grading systems are well established. More difficult is the classification of th作者: 信任 時(shí)間: 2025-4-1 21:10 作者: 豪華 時(shí)間: 2025-4-2 01:25
Circulating Tumour Markers in Breast Cancer,urrently used in clinical practice. Serum marker levels reflect tumour burden, and for this reason they are not sensitive enough to be used for screening and early diagnosis of primary breast cancer. By contrast, the role of tumour markers is established in the diagnosis of recurrent disease and in
